Virus Filtration Market Size Forecast to Reach $6.1 Billion by 2025

Virus Filtration Market size is forecast to reach $6.1 billion by 2025, growing at a CAGR of 12.3% during the forecast period 2020-2025. Virus Filtration retains virus particles on the filter’s surface & within the pored and it uses a membrane barrier to remove both enveloped and non-enveloped viruses. Increasing the development of biologics and the growing pharmaceutical industry are the major factors driving the growth of the market. Escalating demand for biologics therapeutics for the treatment of chronic disease further enhance the overall market demand for virus filtration during the forecast period 2020-2025.

Key Takeaways

  • North America dominates the Virus Filtration Market in 2019 owing to the rising prevalence of chronic diseases like cancer, diabetes, and autoimmune disorder. The Virus Filtration Market scope for different regions will be provided in the final report.
  • Increasing focus on the development of vaccines, protein therapeutics, & gene therapy products and the adoption of single-use technologies is likely to aid in the market growth of Virus Filtration Market.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Virus Filtration Market report.
  • Strict regulations associated with the filtration product validation along with the consolidated market is set to create hurdles for the Virus Filtration Market.

Product – Segment Analysis

The Kits & Reagents consumables segment held the largest share in the Virus Filtration Market in 2019 and is estimated to grow at a CAGR of 10.6% during the forecast period 2020-2025 due to the increased usage of those products for virus filtration. Rising focus on the development of vaccines, protein therapeutics, blood products, cellular therapy products, gene therapy products, tissue products, and stem cell products is expected to boost the demand for consumables including reagents, kits, and membranes. The reagents help to reduce the potential of iatrogenic transmission of pathogenic viruses. In the process evaluation, the reagents help to identify the virus that is likely to contaminate the cell-substrate or any other reagents or materials used in the process. Kits & Reagent’s consumables segment is increasing with the increasing focus on the development of vaccines, protein therapeutics, blood products, and gene therapy products. The instrument is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025 owing to the escalating demand for biologic therapy for the treatment of chronic disease.

Technology – Segment Analysis

The filtration held the largest share in the Virus Filtration Market in 2019. It uses a membrane barrier to retain virus particles. It is a size-based removal method that uses a specifically designed polymeric membrane to retain virus particles on the surface and within the pores of the membrane. The critical performance parameters are typically the log reduction value (LRV) and the throughput. These parameters may be affected by many interacting factors such as viral load, protein concentration, presence of foulants, pressure, operating flux, ionic strength, and stop-start interruptions. Chromatography has constant fluid-flow rates during operations but may have differing pumping pressures. In contrast, virus filtration necessitates constant pumping pressures but may have varying flow rates because the filters become clogged or fouled. Filtration is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025 owing to the increased adoption of these products in the manufacturing of biologics & medical devices along with the increasing need in biopharmaceutical and biotechnology.

Geography – Segment Analysis

North America dominated the Virus Filtration Market in 2019 with a share of more than 41%, followed by the Asia Pacific owing to the increasing demand for advanced biologics production. The increasing number of cancer patients, growing demand for therapeutic biologics, and rising government support for the biotechnology and pharmaceutical industry are increasing the growth of the virus filtration market in this region.

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the increasing adoption of single-use technologies and the growing pharmaceutical industry.

Drivers – Virus Filtration Market  

  • Escalating demand for biologics therapeutics for the treatment of chronic disease

Escalating demand for biologics therapeutics for the treatment of chronic disease is increasing the growth of the virus filtration. Virus filtration uses a membrane barrier to remove both enveloped and non-enveloped viruses that retain virus particles on the filter’s surface and is based on virus size. The growing pervasiveness of chronic diseases such as blood disorders, cancer, diabetes, deficiency of growth hormones, and other autoimmune disorders that surge the demand for biologics. Also, the rise in the adoption of bio therapeutics owing to lesser adverse effects is boosting the market. Biological therapeutic products are produced using mammalian cell lines. Hence, regulatory agencies have mandated that manufacturers evaluate the risks of virus contamination and take necessary measures to mitigate these risks. Thus, increasing the growth of the virus filtration market during the forecast period 2020-2025.

  • Increasing focus on development of vaccines, protein therapeutics and gene therapy products and adoption of single use technologies

Increasing focus on the development of vaccines, protein therapeutics, and gene therapy products and the adoption of single-use technologies is increasing the growth of the virus filtration market. Single-use technology is a part of biopharmaceutical manufacturing and has become a standard platform along with virus filtration for final polishing that is the removal of residual host cell proteins, DNA, and viruses. Single-use systems reduce the need to conduct SIP operations, they help ease compliance burdens for biopharma manufacturers. Single-use filtration systems are used for purification and removal of viruses, plasmids, and other contaminants that are possibly present within the liquid components during the biological manufacturing process. Moreover, It also provides higher safety in biologic processing for the filtration of small, non-enveloped viruses as well as viral strains that are resistant to chemical inactivation. Thus, increasing the growth of the virus filtration market during the forecast period 2020-2025.

Challenges – Virus Filtration Market

  • Strict regulations associated with the filtration product validation along with the consolidated market 

Some of the factors that may impede the growth of the Virus Filtration Market are strict regulations associated with the filtration product validation along with the consolidated market and rising competition among the manufacturers.

Virus Filtration Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Virus Filtration Market. In 2019, the Virus Filtration Market share is consolidated by the top ten players present in the market. Virus Filtration, the top 10 companies are Merck KgaA, Thermo Fisher Scientific Inc., Charles River Laboratories International Inc., GE Healthcare, Lonza Group Ltd., Wuxi Pharma Tech, Danaher Corporation, Asahi Kasei Medical Co. Ltd., and Pall Corporation.

Acquisitions/Product Launches

  • In August 2015, Danaher Corporation acquired Pall Corporation, a leading provider of virus filtration products.
  • In October 2016, Pall Corporation launched the Cadence BioSMB Process System for continuous and single-use biopharmaceutical production.